Web Exclusives

Cancer biorepository speeds clinical trials and drug development

A warehouse of patient-donated biological data expedites trial accrual, reduces trial sizes, saves money, and may speed drugs through the drug development pipeline.

Scientific basis for cognitive complaints of breast cancer patients found

A new study shows a significant correlation between poorer performance on neuropsychological tests and memory complaints in posttreatment, early-stage breast cancer patients—particularly those who have undergone combined chemotherapy and radiation.

Lung biomarker testing hindered by insufficient tissue samples

The biggest challenges in incorporating biomarker testing into lung cancer care occur when a tissue sample is of insufficient size or quality.

Screening for ovarian cancer uses neighboring cells

Pioneering biophotonics technology is the first screening method to detect the early presence of ovarian cancer in humans

Prostate cancer risk higher for obese men even after benign biopsy

Obese men were more likely to have precancerous lesions detected in their benign prostate biopsies compared with nonobese men, and they were at a greater risk for subsequently developing prostate cancer, according to a new study.

Chest docs advise CT screening for lung cancer in high-risk patients

The American College of Chest Physicians now recommends offering low-dose computed tomography scanning to persons at high risk for lung cancer.

Skin cancer linked to future risk of other cancers

White people who have types of skin cancer other than melanoma may be at increased risk of having other forms of cancer in the future, according to a new study.

Radiation damage to lungs and heart can be limited by commonly used drug

Unavoidable damage caused to the heart and lungs by radiotherapy treatment of tumors in the chest region can be limited by the administration of an ACE inhibitor, according to new research.

Exercise may lower breast cancer risk by altering estrogen metabolism

Aerobic exercise may reduce breast cancer risk by changing estrogen metabolism to produce more of the metabolites that keep the disease at bay.

Anti-HER2 treatments may benefit some patients with lung cancer

A new retrospective study suggests that anti-HER2 treatments have anti-cancer effects in a small subset of patients with advanced non-small cell lung cancer who harbor specific mutations in the HER2 protein.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs